The biotech aims to deliver more comprehensive healthcare solutions across its diversified businesses in branded pharmaceuticals, generics, and devices & services in key therapeutic areas with this deal.
Endo Pharmaceuticals has entered into an agreement to acquire privately held Qualitest Pharmaceuticals for approximately $1.2 billion in cash.
Qualitest, the sixth-largest US generics company as measured by [...]
PharmExec Blog
Follow Us
RSS
Bookstore
Endo Pharmaceuticals Acquires Qualitest for $1.2 Billion